EP2854768 - Bibliographic data

COMPOSITIONS PHARMACEUTIQUES DE PEMETREXED

Last update 06/07/2025
Legal status Brevet déchu
Origin Euro-PCT

(73) Holder

Fresenius Kabi Oncology Limited

B- 310, Som Datt Chambers - I Bhikaji Cama Place
New Delhi 110 066
Inde
(72) Inventors

Dhiraj KHATTAR

Fresenius Kabi Oncology Limited Echelon Institutional Area Plot No - 11 Sector-32 Haryana
Gurgaon 122 001
Inde

Rajesh KHANNA

Fresenius Kabi Oncology Limited Echelon Institutional Area Plot No - 11 Sector-32 Haryana
Gurgaon 122 001
Inde

Mukti YADAV

Fresenius Kabi Oncology Limited Echelon Institutional Area Plot No - 11 Sector-32 Haryana
Gurgaon 122 001
Inde

Krishanu BURMAN

Fresenius Kabi Oncology Limited Echelon Institutional Area Plot No - 11 Sector-32 Haryana
Gurgaon 122 001
Inde
(74) Agent

Mail recipient

Fresenius Kabi Deutschland GmbH

Patent Department Borkenberg 14
61440 Oberursel
Allemagne

(21) Request number EP13730070.3
(22) Request date 30/05/2013

(11) Publication number EP2854768
Publication date 22/03/2017

(54) Title of the invention COMPOSITIONS PHARMACEUTIQUES DE PEMETREXED
(51) International classification A61K 9/08A61K 9/19A61K  47/18A61K 31/519A61P 35/00
International classification (before reform) None

Claimed priority

(31) Number: 1648DE2012
(32) Date: 30/05/2012
(33) Country: IN

Initial application None
Divisional application EP17161417.5 /EP3210629 None

Expected annuity Annuity: 5 - Amount: 55 € - Due date 31/05/2017
Surtax: 5 - Amount: 11 € - Due date 01/12/2017
Last annuity None

Publication None
History

Publication de la délivrance du brevet européen - Legal date 22/03/2017


Modification des informations de priorité du brevet européen - Legal date 17/03/2017


Entrée en période de grâce du brevet d'invention - Legal date 01/06/2017


Déchéance du brevet d'invention après période de grâce - Legal date 31/05/2017